1Recent evidence shows that the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 2 is highly sensitive to interferons (IFNs). However, the underlying antiviral effectors remain to be 3 defined. Here, we show that Zinc finger antiviral protein (ZAP) that specifically targets CpG 4 dinucleotides in viral RNA sequences restricts SARS-CoV-2. We demonstrate that ZAP and its 5 cofactors KHNYN and TRIM25 are expressed in human lung cells. Type I, II and III IFNs all 6 strongly inhibited SARS-CoV-2 and further induced ZAP expression. Strikingly, SARS-CoV-2 and 7 its closest relatives from bats show the strongest CpG suppression among all known human and bat 8 coronaviruses, respectively. Nevertheless, knock-down of ZAP significantly increased SARS-CoV-9 2 production in lung cells, particularly upon treatment with IFN- or IFN-. Thus, our results 10 identify ZAP as an effector of the IFN response against SARS-CoV-2, although this pandemic 11 pathogen may be preadapted to the low CpG environment in humans. 12 13 Highlights 14 SARS-CoV-2 and its closest bat relatives show strong CpG suppression 15 IFN-β, - and - inhibit SARS-CoV-2 with high efficiency 16 ZAP restricts SARS-CoV-2 and contributes to the antiviral effect of IFNs 17 18 3